Home/ Supplements/ Berberine/ Berbemycin

Berbemycin

product on market Capsule XYMOGEN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Berberine and Oregon grape are supported by moderate evidence for managing glycemic response and metabolic health. Uva Ursi and grapefruit seed extract have limited research regarding their efficacy in human clinical settings. Overall, the evidence coverage for this specific ingredient combination is minimal.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Berbemycin
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

390 mg
Market median: 500.0mg (234 products) 95 studies (A:0, B:35)
Market median: 250.0mg (50 products)
Uva Ursi Leaf Extract
180 mg
Market median: 500.0mg (234 products) 95 studies (A:0, B:35)

Other Ingredients

Hypromellose Water Hydroxypropyl Methylcellulose Silica Ascorbyl Palmitate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take two capsules once or twice daily, or as directed by your healthcare professional.

Warnings & Precautions

Professional use only Not for resale on third-party websites, including, but not limited to, Amazon and eBay.

Consult your healthcare professional before use. Do not use if tamper seal is damaged.

Individuals taking medication should discuss potential interactions with their healthcare professional.

Storage: Keep closed in a cool, dry place out of reach of children.

Formulation Notes

Berbemycin features berberine, a plant alkaloid broadly used in traditional Ayurvedic and Chinese herbal practices that has exhibited clinical benefits for supporting healthy microbial activity in the gastrointestinal tract. The complementary ingredients Oregon grape root, which naturally contains concentrated berberine, and extracts of grapefruit seed and uva ursi also influence microbial activity.

Formulated to exclude: Wheat, gluten, yeast, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, sesame, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.

Supports healthy microbial balance

Vegetarian Caps

Additional Information

Storage: Keep closed in a cool, dry place out of reach of children.

ePV (ePedigree Verification) Vegetarian Caps GMP Compliant Third-Party Verified

Scan to learn more! This package is completely recyclable

Metadata

Product Details

UPC / SKU7 22537 51208 4
DSLD Entry Date2023-06-22
Product TypeOther Combinations
FormCapsule
BrandXYMOGEN
DSLD ID294639
Data Updated2026-04-11
Research

Research Evidence

98
Research Sources
55
Avg Quality
48
Systematic Review
39
Meta Analysis
4
Rct
4
Clinical Trial
1
Other
1
Narrative Review
1
Openfda Safety
B Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2018 PubMed DOI
B Effects berberine-silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Clinical nutrition ESPEN 2022 PubMed DOI
B Efficacy and safety of berberine for several cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 PubMed DOI
B Effect of Berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Complementary therapies in medicine 2019 PubMed DOI
B Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta Analysis The Journal of nutrition 2023 PubMed DOI
B The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
Meta Analysis Journal of translational medicine 2024 PubMed DOI
B Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature
Systematic Review International journal of molecular sciences 2024 PubMed DOI
B Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis The American journal of Chinese medicine 2019 PubMed DOI
B Effects of Berries, Phytochemicals, and Probiotics on Atherosclerosis through Gut Microbiota Modification: A Meta-Analysis of Animal Studies
Meta Analysis International journal of molecular sciences 2023 PubMed DOI
B Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial
Rct JAMA network open 2025 PubMed DOI
View all evidence for Berberine →
Compare

Similar Products

View all Berberine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.